Publication:
Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial

Citation
Mainga Hamaluba, Rob W. van der Pluijm, Joseph Weya, Patricia Njuguna, Mwanajuma Ngama, Peter Kalume, Gabriel Mwambingu, Caroline Ngetsa, Juliana Wambua, Mwanamvua Boga, Neema Mturi, Altaf A. Lal, Arshad Khuroo, Walter R.J. Taylor, Sónia Gonçalves, Olivo Miotto, Mehul Dhorda, Brian Mutinda, Mavuto Mukaka, Naomi Waithira, Richard M. Hoglund, Mallika Imwong, Joel Tarning, Nicholas P.J. Day, Nicholas J. White, Philip Bejon, Arjen M. Dondorp (2021). Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/77832.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
View online Resources
Collections